We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Kura Sushi USA
KRUS
$422M
| $86.1K | ﹤0.01% |
1,496
+314
| +27% | +$17.2K |
2026 Q1
1 quarter
|
|
852
USA Today Co
TDAY
$1.02B
| $81.3K | ﹤0.01% |
9,511
-13,385
| -58% | -$101K |
2026 Q1
1 quarter
|
|
853
Alpha Metallurgical Resources
AMR
$2.03B
| $75.7K | ﹤0.01% |
+459
| New | +$87.5K |
2026 Q2
0 quarters
|
|
854
Horace Mann Educators
HMN
$1.88B
| $74K | ﹤0.01% |
+1,432
| New | +$66.5K |
2026 Q2
0 quarters
|
|
855
Mercado Libre
MELI
$94B
| $73K | ﹤0.01% |
+43
| New | +$73.4K |
2026 Q2
0 quarters
|
|
856
Aveanna Healthcare
AVAH
$2.84B
| $72.7K | ﹤0.01% |
8,484
+8,483
| +848,300% | +$59.8K |
2026 Q1
1 quarter
|
|
857
Nebius Group N.V.
NBIS
$46.6B
| $71.3K | ﹤0.01% |
+258
| New | +$51.1K |
2026 Q2
0 quarters
|
|
858
CytomX Therapeutics
CTMX
$523M
| $71.1K | ﹤0.01% |
+18,972
| New | +$72.4K |
2026 Q2
0 quarters
|
|
859
OSI Systems
OSIS
$3.14B
| $65.8K | ﹤0.01% |
+301
| New | +$73.7K |
2026 Q2
0 quarters
|
|
860
Caris Life Sciences
CAI
$9.14B
| $65.1K | ﹤0.01% |
3,655
+3,649
| +60,817% | +$65.3K |
2026 Q1
1 quarter
|
|
861
Venture Global Inc
VG
$32.1B
| $63.7K | ﹤0.01% |
5,722
-877,825
| -99% | -$11.1M |
2026 Q1
1 quarter
|
|
862
Ultragenyx Pharmaceutical
RARE
$1.57B
| $62.1K | ﹤0.01% |
+1,861
| New | +$46.2K |
2026 Q2
0 quarters
|
|
863
MGM Resorts International
MGM
$7.26B
| $61.9K | ﹤0.01% |
+1,295
| New | +$53.8K |
2026 Q2
0 quarters
|
|
864
Banner Corp
BANR
$2.49B
| $61.8K | ﹤0.01% |
930
-19,690
| -95% | -$1.28M |
2026 Q1
1 quarter
|
|
865
Planet Labs
PL
$4.99B
| $61.7K | ﹤0.01% |
+1,862
| New | +$68.8K |
2026 Q2
0 quarters
|
|
866
OneMain Financial
OMF
$6.54B
| $61K | ﹤0.01% |
+1,000
| New | +$56.3K |
2026 Q2
0 quarters
|
|
867
LSI Industries
LYTS
$734M
| $59.1K | ﹤0.01% |
+2,222
| New | +$51.4K |
2026 Q2
0 quarters
|
|
868
AeroVironment
AVAV
$5.97B
| $57.9K | ﹤0.01% |
+351
| New | +$62.8K |
2026 Q2
0 quarters
|
|
869
Navan Inc
NAVN
$6.93B
| $53.4K | ﹤0.01% |
+2,336
| New | +$42.8K |
2026 Q2
0 quarters
|
|
870
TMC The Metals Company
TMC
$1.17B
| $49K | ﹤0.01% |
+11,058
| New | +$57.6K |
2026 Q2
0 quarters
|
|
871
StubHub Holdings
STUB
$2.26B
| $46.8K | ﹤0.01% |
+3,633
| New | +$32.1K |
2026 Q2
0 quarters
|
|
872
Moderna
MRNA
$98.1B
| $46.2K | ﹤0.01% |
+659
| New | +$34.1K |
2026 Q2
0 quarters
|
|
873
CRISPR Therapeutics
CRSP
$4.88B
| $45.1K | ﹤0.01% |
+827
| New | +$43.6K |
2026 Q2
0 quarters
|
|
874
Innovex International
INVX
$2.06B
| $42.7K | ﹤0.01% |
1,721
+574
| +50% | +$15.6K |
2026 Q1
1 quarter
|
|
875
PennyMac Financial
PFSI
$3.09B
| $41.2K | ﹤0.01% |
473
-11,913
| -96% | -$1.04M |
2026 Q1
1 quarter
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.